RJA
SRGA

Raymond James & Associates’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Raymond James & Associates’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,273
Closed -$74K – 4342
2021
Q3 		$74K Sell
2,273
-5
-0.2% -$183 ﹤0.01% 3880
2021
Q2 		$95K Buy
+2,278
New +$117K ﹤0.01% 3844

Other funds holding SRGA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Raymond James & Associates's SRGA Position: Q4 2021 in Review

Raymond James & Associates sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 2,273 shares — an estimated $74K sold.

Raymond James & Associates first reported a position in SRGA in Q2 2021 and held it in 2 quarters. The position peaked at $95K in Q2 2021. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

  • Raymond James & Associates reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 2,273 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $74K.
  • Raymond James & Associates first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Raymond James & Associates's Surgalign Holdings, Inc. Common Stock position peaked at $95K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.